Applied Molecular Transport Inc.
Delivery constructs for transcytosis and related methods

Last updated:

Abstract:

The present disclosure provides non-naturally occurring fusion molecules comprising therapeutic cargo moieties, such as IL-22 with a carrier. The disclosure also provides methods and compositions for the production, purification, refolding, formulation, and administration of fusion molecules. Methods and for using the purified molecules to treat and prevent diseases or disorders are also provided herein.

Status:
Grant
Type:

Utility

Filling date:

15 Jun 2020

Issue date:

8 Jun 2021